Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -3.267\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a) O=C(CSc1nnc(CNc2ccc(F)cc2)n1CC1CCCO1)Nc1ccccc1
b) O=C(COC(=O)CCc1nc2ccccc2c(=O)[nH]1)NC(=O)NC1CCCC1
c) Cc1ccc(S(=O)(=O)NC(C)C(=O)Nc2ccc3c(c2)OCO3)cc1
d) CCC(C)NC(=O)CSc1nc2c(sc3ccccc32)c(=O)n1CCCN1CCOCC1
Answer: d. CCC(C)NC(=O)CSc1nc2c(sc3ccccc32)c(=O)n1CCCN1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)NC(=O)CSc1nc2c(sc3ccccc32)c(=O)n1CCCN1CCOCC1
CCC(C)NC(=O)CSc1nc2c(sc3ccccc32)c(=O)n1CCCN1CCOCC1
2-[[3-(3-morpholin-4-ylpropyl)-4-oxo-[1]benzothiolo[3,2-d]pyrimidin-2-yl]sulfanyl]-N-butan-2-ylacetamide